NLRC3 and AIM2 (Figure 2A) were the only two genes that showed statistical difference between stage IV CRC and stages I-III CRC, wherein their expression in stage IV CRC was significantly lower than the other stages of CRC. This evidence concerns the gene AIM2 and colorectal carcinoma.